Gothamist

A non-profit newsroom, powered by WNYC.

Gothamist

WNYC Listen Live

Donate

 

 

News

A drug-resistant skin infection has come to NYC. Here’s what you need to know about it.


By

Verónica Del Valle

Published May 15, 2023


Share

FacebookTwitterRedditEmail


Never miss a story

 Email address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .

Two NYC cases of the fungus Trichophyton indotineae are a first for the U.S.

 

CDC


By

Verónica Del Valle

Published May 15, 2023


Share

FacebookTwitterRedditEmail


We rely on your support to make local news available to all

Make your contribution now and help Gothamist thrive in 2026. Donate today

Gothamist is funded by sponsors and member donations

New York and federal health officials have issued a warning about two cases of a drug-resistant, highly contagious skin infection in New York City.

The new report, published late last week by the Centers for Disease Control and Prevention, linked two local cases of ringworm rash to an aggressive strain of a fungus named Trichophyton indotineae. This species is common in South Asia, and it’s a type of fungus known as a dermatophyte mold, meaning it needs protein in the skin to grow.

But one of the NYC cases could not be tied to overseas travel, suggesting the germ is spreading locally in the U.S. Despite being resistant to first-choice drugs, this fungal strain is still treatable with other medications.

Dr. Avrom Caplan, a dermatologist at NYU Langone Health, alerted public health officials in February of the two patients, whose conditions did not improve after receiving standard oral treatment. Both had severe cases of ringworm rash, which spreads easily through skin-to-skin contact. Caplan treated one of the patients at Langone and co-authored the CDC report.

He said the rashes on this patient were more inflamed than the average case of ringworm. Oral medications also failed to alleviate her symptoms.

"We've been alerted to this infection by our colleagues in India and elsewhere over the past number of years," Caplan said. "This particular patient had many of the features that they have been reporting."

Genomic sequencing a month later revealed both women had contracted an infection caused by the fungus Trichophyton indotineae independently of one another. The ringworm rashes caused by this species are often inflamed and itchy. They typically spread on the face, body, thighs and pubic area.

An example of a ringworm rash caused by a related fungus, Trichophyton rubrum.

BSIP/UIG Via Getty Images

The first of the two cases began in the summer of 2021, when a 28-year-old pregnant woman developed widespread rashes. After giving birth in January 2022 and being prescribed antifungal medication, her rashes persisted. She had had no recent international travel.

The second patient, a 47-year-old woman, first developed ringworm while visiting Bangladesh, where the strain is common. Once she returned to the U.S., doctors prescribed her four different treatments to no avail. Her husband and son have since reported similar rashes.

However, Caplan said community spread is "very hard to prove at this point" because of the small number of cases. He said, despite the CDC report, the threat level is low for most people, and that the warning is mostly a heads-up for doctors who encounter this rare condition. The report included pictures of what the two infections looked like.

"People should not be worried about this," he said. "The important takeaway points here are for clinicians in particular and for public health authorities. So, we know public health authorities are looking out for this, they've been looking out for it."

Despite the fungus's novelty in the U.S., health officials have previously reported cases throughout Asia, Europe, and Canada, according to the CDC. The agency linked the rise of the strain to the "inappropriate use" of common topical steroids used to treat the infection.

Both women identified in the CDC report recovered from their rashes after receiving extended therapies.

The biggest threat regarding the rashes is chronic relapse, which, Caplan said, is common among patients in other countries.

Though Caplan stressed that the average person should not be on high alert when it comes to Trichophyton indotineae, he said those with reason to believe they're infected should immediately "seek advice from a clinician instead of using over-the-counter creams or medications obtained through friends and loved ones.

Officials from the New York City Department of Health did not immediately respond to a request for comment.

Tagged

new york city

infection

public health

Health and Science


Verónica Del Valle

Read more

Gothamist is funded by sponsors and member donations


Gothamist is funded by sponsors and member donations


MORE news

Central Park birders, others remember 63-year-old woman killed in park

People who said they knew her described her as an artist and a familiar presence in the Ramble.

By

Charles Lane

Published Sep 28, 2026 at 7:04 p.m. ET


Dump truck driver hits and kills cyclist on 34th Street in Midtown, NYPD says

It's the latest in a string of hit-and-run deaths in the city in recent months.

By

Liam Quigley

News

Dump truck driver hits and kills cyclist on 34th Street in Midtown, NYPD says

It's the latest in a string of hit-and-run deaths in the city in recent months.

By

Liam Quigley


New ingredient mandated for Latin American kitchen, restaurant plates in NJ

By

Arya Sundaram

A Brooklyn jail cell filled with smoke. The emergency button failed, a lawyer said.

By

Samantha Max

Crews launch tunnel machines to dig first new Hudson River rail tunnels since 1910

By

Michael Sol Warren


Never miss a story

Catch up on the most important headlines with a roundup of essential NYC stories, delivered to your inbox daily.

Sign upEmail address

By submitting your information, you're agreeing to receive communications from New York Public Radio in accordance with our Terms .